Effect of Curcumin and/or Nigella sativa‎ on bone density and quality of life in postmenopausal women with osteoporosis or osteopenia

IF 1.7 Q2 Medicine
Farzaneh Usefian , Azizeh Farshbaf- Khalili , Mojgan Mirghafourvand , Majid Mobasseri , Sakineh Mohammad-Alizadeh-Charandabi
{"title":"Effect of Curcumin and/or Nigella sativa‎ on bone density and quality of life in postmenopausal women with osteoporosis or osteopenia","authors":"Farzaneh Usefian ,&nbsp;Azizeh Farshbaf- Khalili ,&nbsp;Mojgan Mirghafourvand ,&nbsp;Majid Mobasseri ,&nbsp;Sakineh Mohammad-Alizadeh-Charandabi","doi":"10.1016/j.aimed.2024.03.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>This study aimed to assess the effect of Curcumin and/or Nigella sativa‎ on bone density parameters (primary outcome) and quality of life (secondary outcome) in postmenopausal women with primary osteoporosis or osteopenia.</p></div><div><h3>Design</h3><p>Randomized controlled trial with factorial design.</p></div><div><h3>Methods</h3><p>120 postmenopausal women aged 50–65 years with primary osteoporosis or osteopenia were equally randomized into four groups receiving daily capsules for six months; 1) nanomicellar Curcumin 80 mg, 2) Nigella sativa‎ oil 1000 mg, 3) both, 4) placebo. All groups also received conventional treatments. In addition to the baseline assessment, bone mineral density (BMD), T-score, and Z-score were assessed at six months and quality of life (using the menopause-specific quality of life questionnaire) at two, four, and six months of the interventions.</p></div><div><h3>Results</h3><p>Five cases were lost to follow-up. No serious side events were reported. After the interventions, significant increases were observed in the femoral neck-BMD within all groups (p&lt;0.01) as well as in the lumbar spine-BMD within the Nigella sativa and nanomicellar Curcumin-Nigella sativa groups (p&lt;0.05). However, there was no statistically significant difference between the groups in terms of bone density parameters and overall quality of life score. In the Curcumin group, vasomotor dimension (adjusted difference −0.90, 95% CI: −1.62 to −0.18) and in the Nigella, sativa‎ group vasomotor (-0.76, −1.50 to −0.03) and physical (-0.61, −1.09 to −0.14) dimensions of quality of life score were significantly better than the placebo group.</p></div><div><h3>Conclusions</h3><p>The addition of Curcumin, Nigella sativa‎ oil, or their combination does not significantly improve bone density parameters and overall quality of life of postmenopausal women with primary osteoporosis or osteopenia compared to routine treatment, but it can improve vasomotor function of quality of life. We suggest conducting long-term interventions based on the results.</p></div>","PeriodicalId":7343,"journal":{"name":"Advances in integrative medicine","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in integrative medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212958824000284","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

This study aimed to assess the effect of Curcumin and/or Nigella sativa‎ on bone density parameters (primary outcome) and quality of life (secondary outcome) in postmenopausal women with primary osteoporosis or osteopenia.

Design

Randomized controlled trial with factorial design.

Methods

120 postmenopausal women aged 50–65 years with primary osteoporosis or osteopenia were equally randomized into four groups receiving daily capsules for six months; 1) nanomicellar Curcumin 80 mg, 2) Nigella sativa‎ oil 1000 mg, 3) both, 4) placebo. All groups also received conventional treatments. In addition to the baseline assessment, bone mineral density (BMD), T-score, and Z-score were assessed at six months and quality of life (using the menopause-specific quality of life questionnaire) at two, four, and six months of the interventions.

Results

Five cases were lost to follow-up. No serious side events were reported. After the interventions, significant increases were observed in the femoral neck-BMD within all groups (p<0.01) as well as in the lumbar spine-BMD within the Nigella sativa and nanomicellar Curcumin-Nigella sativa groups (p<0.05). However, there was no statistically significant difference between the groups in terms of bone density parameters and overall quality of life score. In the Curcumin group, vasomotor dimension (adjusted difference −0.90, 95% CI: −1.62 to −0.18) and in the Nigella, sativa‎ group vasomotor (-0.76, −1.50 to −0.03) and physical (-0.61, −1.09 to −0.14) dimensions of quality of life score were significantly better than the placebo group.

Conclusions

The addition of Curcumin, Nigella sativa‎ oil, or their combination does not significantly improve bone density parameters and overall quality of life of postmenopausal women with primary osteoporosis or osteopenia compared to routine treatment, but it can improve vasomotor function of quality of life. We suggest conducting long-term interventions based on the results.

姜黄素和/或黑麦草对绝经后骨质疏松症或骨质增生妇女骨密度和生活质量的影响
目的本研究旨在评估姜黄素和/或黑麦草对患有原发性骨质疏松症或骨质疏松症的绝经后妇女的骨密度参数(主要结果)和生活质量(次要结果)的影响。方法 将 120 名年龄在 50-65 岁之间、患有原发性骨质疏松症或骨质增生的绝经后妇女平均随机分为四组,每组每天服用姜黄素胶囊 6 个月:1)纳米姜黄素 80 毫克;2)黑升麻油 1000 毫克;3)二者;4)安慰剂。所有组别均接受常规治疗。除了基线评估外,还在干预后的两个月、四个月和六个月评估了骨矿物质密度(BMD)、T-score和Z-score,以及生活质量(使用更年期生活质量问卷)。无严重副作用报告。干预后,所有组的股骨颈-BMD 都有明显增加(p<0.01),黑麦草组和纳米姜黄素-黑麦草组的腰椎-BMD 也有明显增加(p<0.05)。不过,在骨密度参数和总体生活质量评分方面,组间差异无统计学意义。姜黄素组的血管运动维度(调整后差异为-0.90,95% CI:-1.62至-0.18)和黑升麻组的血管运动维度(-0.76,-1.50至-0.03)和身体维度(-0.61,-1.09至-0.14)的生活质量评分明显优于安慰剂组。结论与常规治疗相比,添加姜黄素、黑升麻油或它们的复方制剂并不能明显改善原发性骨质疏松症或骨质疏松症绝经后妇女的骨密度参数和整体生活质量,但可以改善血管运动功能和生活质量。我们建议根据研究结果进行长期干预。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Advances in integrative medicine
Advances in integrative medicine INTEGRATIVE & COMPLEMENTARY MEDICINE-
CiteScore
3.20
自引率
11.80%
发文量
0
审稿时长
15 weeks
期刊介绍: Advances in Integrative Medicine (AIMED) is an international peer-reviewed, evidence-based research and review journal that is multi-disciplinary within the fields of Integrative and Complementary Medicine. The journal focuses on rigorous quantitative and qualitative research including systematic reviews, clinical trials and surveys, whilst also welcoming medical hypotheses and clinically-relevant articles and case studies disclosing practical learning tools for the consulting practitioner. By promoting research and practice excellence in the field, and cross collaboration between relevant practitioner groups and associations, the journal aims to advance the practice of IM, identify areas for future research, and improve patient health outcomes. International networking is encouraged through clinical innovation, the establishment of best practice and by providing opportunities for cooperation between organisations and communities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信